CHRONIC WEIGHT MANAGEMENT
Clinical trials for CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for shedding pounds in obesity trial
Disease control CompletedThis study tested an experimental drug called aleniglipron (GSBR-1290) to help people with obesity or overweight lose weight. About 85 adults took either the drug or a placebo for 44 weeks, along with diet and exercise. The main goals were to check safety and side effects, and to…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated May 15, 2026 12:02 UTC
-
New obesity pill shows promise in long-term weight control
Disease control CompletedThis study looked at the long-term safety and effectiveness of HRS-7535 tablets for weight management in 81 adults with obesity who had already completed a 36-week treatment course. Participants took the drug for an additional 32 weeks to see how much weight they lost and if any …
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New pill shows promise for shedding pounds in overweight adults
Disease control CompletedThis study tested a new tablet called ASC30 to help people who are overweight or obese and have related health problems lose weight. About 125 adults took either the study drug or a placebo for 13 weeks. Researchers measured weight loss, waist size, and safety to see if the drug …
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New combo shot targets obesity in early trial
Symptom relief CompletedThis early-stage study tested a new drug called ASC47, given as a shot under the skin, together with semaglutide (a weight-loss medication) in 28 adults with obesity. The main goal was to check safety and side effects, and researchers also looked at changes in body weight over 10…
Matched conditions: CHRONIC WEIGHT MANAGEMENT
Phase: PHASE1 • Sponsor: Ascletis Pharma (China) Co., Limited • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC